Farhat Karima, Stavenuiter Andrea W D, Beelen Rob H J, Ter Wee Piet M
Department of Nephrology,1 VU University Medical Center, and Department of Molecular Cell Biology and Immunology,2 VU University, Amsterdam, Netherlands.
Perit Dial Int. 2014 Jan-Feb;34(1):114-23. doi: 10.3747/pdi.2011.00332.
Peritoneal dialysis (PD) is associated with functional and structural changes of the peritoneal membrane, also known as peritoneal remodeling. The peritoneal membrane is affected by many endogenous and exogenous factors such as cytokines, PD fluids, and therapeutic interventions. Here, we present an overview of various studies that have investigated pharmacologic interventions aimed at regression of peritoneal damage and prolongation of PD treatment.
腹膜透析（PD）与腹膜的功能和结构变化相关，也称为腹膜重塑。腹膜受到许多内源性和外源性因素的影响，如细胞因子、腹膜透析液和治疗干预措施。在此，我们概述了各项研究，这些研究调查了旨在逆转腹膜损伤和延长腹膜透析治疗时间的药物干预措施。
